Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C13H16N6O3.C6H6O3S |
| Molecular Weight | 462.48 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 1 / 1 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
OS(=O)(=O)C1=CC=CC=C1.C[C@H]2COCCN2C3=NC(C)=C(C(=N3)N4C=CN=C4)[N+]([O-])=O
InChI
InChIKey=GPJYNQNPOAOBPJ-FVGYRXGTSA-N
InChI=1S/C13H16N6O3.C6H6O3S/c1-9-7-22-6-5-18(9)13-15-10(2)11(19(20)21)12(16-13)17-4-3-14-8-17;7-10(8,9)6-4-2-1-3-5-6/h3-4,8-9H,5-7H2,1-2H3;1-5H,(H,7,8,9)/t9-;/m0./s1
| Molecular Formula | C6H6O3S |
| Molecular Weight | 158.175 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
| Molecular Formula | C13H16N6O3 |
| Molecular Weight | 304.3045 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ABSOLUTE |
| Additional Stereochemistry | No |
| Defined Stereocenters | 1 / 1 |
| E/Z Centers | 0 |
| Optical Activity | UNSPECIFIED |
Approval Year
| Substance Class |
Chemical
Created
by
admin
on
Edited
Tue Apr 01 16:28:43 GMT 2025
by
admin
on
Tue Apr 01 16:28:43 GMT 2025
|
| Record UNII |
YJN0IQX3S4
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Code | English | ||
|
Preferred Name | English | ||
|
Code | English | ||
|
Code | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Code | English | ||
|
Code | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
T-902611
Created by
admin on Tue Apr 01 16:28:43 GMT 2025 , Edited by admin on Tue Apr 01 16:28:43 GMT 2025
|
PRIMARY | |||
|
350595-61-8
Created by
admin on Tue Apr 01 16:28:43 GMT 2025 , Edited by admin on Tue Apr 01 16:28:43 GMT 2025
|
PRIMARY | |||
|
YJN0IQX3S4
Created by
admin on Tue Apr 01 16:28:43 GMT 2025 , Edited by admin on Tue Apr 01 16:28:43 GMT 2025
|
PRIMARY | |||
|
9890530
Created by
admin on Tue Apr 01 16:28:43 GMT 2025 , Edited by admin on Tue Apr 01 16:28:43 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
SALT/SOLVATE -> PARENT | |||
|
|
SALT/SOLVATE -> PARENT | |||
|
|
SALT/SOLVATE -> PARENT | |||
|
|
SALT/SOLVATE -> PARENT | |||
|
|
SALT/SOLVATE -> PARENT | |||
|
|
SALT/SOLVATE -> PARENT | |||
|
|
PARENT -> SALT/SOLVATE |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
ACTIVE MOIETY |
Class Antivirals: Small molecules; Mechanism of Action: Cytomegalovirus replication inhibitor; Highest Development Phase: Discontinued for Cytomegalovirus infection; Most Recent Events: 17 Jun 2002 Discontinued for Phase-II for Cytomegalovirus infections (PO)
|
||
|
ACTIVE MOIETY |
Synthesis of T-902611.
|
||
|
ACTIVE MOIETY |
the nitropyrimidines (for example, T-0902611) inhibit HCMV.
|